ellipticine has been researched along with etoposide in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (6.25) | 18.7374 |
| 1990's | 9 (28.13) | 18.2507 |
| 2000's | 8 (25.00) | 29.6817 |
| 2010's | 11 (34.38) | 24.3611 |
| 2020's | 2 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Hwang, HJ; Kim, JS; Kim, YS; Lee, EJ; Lee, SK; Park, HJ; Ryu, CK; Suh, ME; Yi, YJ | 1 |
| Choo, HY; Kim, JS; Lee, HJ; Lee, IK; Lee, SK; Park, HJ; Rhee, HK; Ryu, CK; Suh, ME | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Estévez-Braun, A; Jiménez-Alonso, S; Machín, F; Orellana, HC; Pérez-Sacau, E; Ravelo, AG | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Brimble, MA; Lorenzo-Castrillejo, I; Machín, F; Sperry, J | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Akkarawongsapat, R; Jariyawat, S; Kasisit, J; Kongkum, N; Napaswad, C; Piyachaturawat, P; Pohmakotr, M; Reutrakul, V; Suksen, K; Tuchinda, P | 1 |
| Mandi, P; Nantasenamat, C; Pingaew, R; Prachayasittikul, S; Prachayasittikul, V; Ruchirawat, S | 1 |
| Mandi, P; Nantasenamat, C; Pingaew, R; Prachayasittikul, S; Prachayasittikul, V; Ruchirawat, S; Saekee, A | 1 |
| Cao, HT; Chau, MV; Cho, WJ; Jin, Y; Khadka, DB; Kwon, Y; Le, TN; Nguyen, HT; Shin, S; Tran, GH; Van, HT; Zhao, C | 1 |
| Nantasenamat, C; Pingaew, R; Prachayasittikul, S; Prachayasittikul, V; Ruchirawat, S; Worachartcheewan, A | 1 |
| Bist, G; Kadayat, TM; Kwon, Y; Lee, ES; Lee, HJ; Park, S; Shrestha, A; Thapa Magar, TB | 1 |
| Liu, Y; Xu, Z; Zhao, SJ | 1 |
| Hwang, SY; Jeon, KH; Kadayat, TM; Katila, P; Kim, D; Kunwar, S; Kwon, Y; Lee, ES; Park, S | 1 |
| Guo, H; Sun, S; Wang, G | 1 |
| Sumner, AT | 1 |
| Hsu, MT; Wong, ML | 1 |
| Shin, CG; Snapka, RM | 1 |
| Evans, HH; Horng, MF; Mencl, J; Ricanati, M | 1 |
| Charcosset, JY; Garbay-Jaureguiberry, C; Jacquemin-Sablon, A; Rigaudy, P; Roques, BP | 1 |
| Filatov, MV; Varfolomeeva, EY | 1 |
| Best-Belpomme, M; Nahon, E; Saucier, JM | 1 |
| Frei, H; Würgler, FE | 1 |
| Falaschi, A; Ochem, A; Phan, TN; Tuteja, N; Tuteja, R | 1 |
| Cline, SD; Macdonald, TL; Osheroff, N | 1 |
| Phan, TN; Tuteja, N | 1 |
| Deslandes, E; Gauduchon, P; Godard, T; Poul, JM; Sichel, F | 1 |
| Hait, WN; Nayak, MS; Yang, JM | 1 |
| Pham, XH; Tran, NQ; Tuteja, N; Tuteja, R | 1 |
| Maszewski, J; Polit, JT; Winnicki, K; Żabka, A | 1 |
| Arlt, VM; Feser, K; Indra, R; Mrizova, I; Phillips, DH; Sozeri, O; Stiborova, M; Willis, AJ; Wohak, LE | 1 |
2 review(s) available for ellipticine and etoposide
| Article | Year |
|---|---|
1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships.
Topics: Antineoplastic Agents; Humans; Molecular Structure; Neoplasms; Structure-Activity Relationship; Triazoles | 2019 |
Current status of carbazole hybrids as anticancer agents.
Topics: Antineoplastic Agents; Carbazoles; Cell Cycle Checkpoints; Cell Proliferation; Coumarins; Humans; Indoles; Pyrazoles; Pyrimidines; Structure-Activity Relationship | 2022 |
30 other study(ies) available for ellipticine and etoposide
| Article | Year |
|---|---|
6-Arylamino-7-chloro-quinazoline-5,8-diones as novel cytotoxic and DNA topoisomerase inhibitory agents.
Topics: Antineoplastic Agents; Cell Line, Tumor; DNA Topoisomerases; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Quinazolines; Structure-Activity Relationship; Topoisomerase Inhibitors | 2004 |
Synthesis of 6-chloroisoquinoline-5,8-diones and pyrido[3,4-b]phenazine-5,12-diones and evaluation of their cytotoxicity and DNA topoisomerase II inhibitory activity.
Topics: Caco-2 Cells; Cell Line, Tumor; Cell Proliferation; DNA; Drug Screening Assays, Antitumor; Drug Stability; Enzyme Inhibitors; Humans; Isoquinolines; Molecular Structure; Permeability; Phenazines; Stereoisomerism; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2007 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Design and synthesis of a novel series of pyranonaphthoquinones as topoisomerase II catalytic inhibitors.
Topics: Aldehydes; Antigens, Neoplasm; Catalysis; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Superhelical; Drug Design; Enzyme Inhibitors; Humans; Models, Molecular; Molecular Structure; Naphthoquinones; Protein Binding; Pyrans; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2008 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Pyranonaphthoquinone derivatives of eleutherin, ventiloquinone L, thysanone and nanaomycin A possessing a diverse topoisomerase II inhibition and cytotoxicity spectrum.
Topics: Antineoplastic Agents; Enzyme Inhibitors; Naphthoquinones; Saccharomyces cerevisiae; Topoisomerase II Inhibitors | 2009 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Cytotoxic, antitopoisomerase IIα, and anti-HIV-1 activities of triterpenoids isolated from leaves and twigs of Gardenia carinata.
Topics: Anti-HIV Agents; Antineoplastic Agents, Phytogenic; Drug Screening Assays, Antitumor; Gardenia; HIV-1; Microbial Sensitivity Tests; Molecular Structure; Plant Leaves; Plant Stems; Thailand; Topoisomerase II Inhibitors; Triterpenes | 2013 |
Design, synthesis and molecular docking studies of novel N-benzenesulfonyl-1,2,3,4-tetrahydroisoquinoline-based triazoles with potential anticancer activity.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chlorocebus aethiops; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Hep G2 Cells; Humans; Isoquinolines; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship; Triazoles; Vero Cells | 2014 |
Synthesis, biological evaluation and molecular docking of novel chalcone-coumarin hybrids as anticancer and antimalarial agents.
Topics: Antimalarials; Antineoplastic Agents; Cell Line, Tumor; Chalcone; Chemistry Techniques, Synthetic; Coumarins; Cysteine Endopeptidases; Humans; Molecular Docking Simulation; Plasmodium falciparum; Protein Conformation; Triazoles; Tubulin | 2014 |
Substituted 2-arylquinazolinones: Design, synthesis, and evaluation of cytotoxicity and inhibition of topoisomerases.
Topics: Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Molecular Structure; Quinazolinones; Structure-Activity Relationship; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2015 |
Novel 1,4-naphthoquinone-based sulfonamides: Synthesis, QSAR, anticancer and antimalarial studies.
Topics: Antimalarials; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Hep G2 Cells; Humans; Molecular Structure; Naphthoquinones; Parasitic Sensitivity Tests; Plasmodium falciparum; Quantitative Structure-Activity Relationship; Sulfonamides | 2015 |
Rational design, synthesis, and evaluation of novel 2,4-Chloro- and Hydroxy-Substituted diphenyl Benzofuro[3,2-b]Pyridines: Non-intercalative catalytic topoisomerase I and II dual inhibitor.
Topics: Antineoplastic Agents; Apoptosis; Benzofurans; Biocatalysis; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; DNA; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Drug Design; Humans; Pyridines; Structure-Activity Relationship; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2017 |
Discovery of a 2,4-diphenyl-5,6-dihydrobenzo(h)quinolin-8-amine derivative as a novel DNA intercalating topoisomerase IIα poison.
Topics: Amines; Antineoplastic Agents; Cell Proliferation; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 2021 |
Inhibitors of topoisomerases do not block the passage of human lymphocyte chromosomes through mitosis.
Topics: Amsacrine; Camptothecin; Chromosome Aberrations; Chromosomes, Human; Daunorubicin; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Ellipticines; Ethidium; Etoposide; Humans; In Vitro Techniques; Lymphocytes; Mitosis; Mitoxantrone; Nalidixic Acid; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1992 |
Involvement of topoisomerases in replication, transcription, and packaging of the linear adenovirus genome.
Topics: Adenoviruses, Human; Alkaloids; Blotting, Southern; Camptothecin; Cell Nucleus; Deoxyribonucleoproteins; DNA Replication; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA, Viral; Electrophoresis, Gel, Two-Dimensional; Electrophoresis, Polyacrylamide Gel; Ellipticines; Etoposide; HeLa Cells; Humans; Microscopy, Electron; Templates, Genetic; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Transcription, Genetic | 1990 |
Patterns of strongly protein-associated simian virus 40 DNA replication intermediates resulting from exposures to specific topoisomerase poisons.
Topics: Animals; Camptothecin; Chlorocebus aethiops; Deoxyribonucleoproteins; DNA Replication; DNA, Viral; Ellipticines; Etoposide; Proflavine; Simian virus 40; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1990 |
Relationship between topoisomerase II and radiosensitivity in mouse L5178Y lymphoma strains.
Topics: Amsacrine; Animals; Cells, Cultured; DNA Repair; DNA Topoisomerases, Type II; Ellipticines; Etoposide; Leukemia L5178; Leukemia, Experimental; Mice; Mutation; Radiation Tolerance; Species Specificity; Thymidine Kinase | 1989 |
Attempts to target antitumor drugs toward opioid receptor-rich mouse tumor cells with enkephalin-ellipticinium conjugates.
Topics: Alkaloids; Animals; DNA; DNA Topoisomerases, Type II; Drug Carriers; Ellipticines; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Etoposide; Fluorescence; Mice; Rats; Receptors, Opioid | 1989 |
Active dissociation of Hoechst 33342 from DNA in living mammalian cells.
Topics: Benzimidazoles; DNA; Ellipticines; Etoposide; Fluorescence; HeLa Cells; Humans; Novobiocin; Topoisomerase II Inhibitors | 1995 |
Analysis of the DNA topoisomerase-II-mediated cleavage of the long terminal repeat of Drosophila 1731 retrotransposon.
Topics: Amsacrine; Animals; Base Sequence; DNA; DNA Topoisomerases, Type II; DNA Transposable Elements; Drosophila; Ellipticines; Etoposide; Molecular Sequence Data; Repetitive Sequences, Nucleic Acid | 1993 |
Induction of somatic mutation and recombination by four inhibitors of eukaryotic topoisomerases assayed in the wing spot test of Drosophila melanogaster.
Topics: Animals; Camptothecin; Drosophila melanogaster; Ellipticines; Enzyme Inhibitors; Etoposide; Female; Male; Mutagenicity Tests; Mutation; Recombination, Genetic; Teniposide; Topoisomerase I Inhibitors | 1996 |
Inhibition of DNA unwinding and ATPase activities of human DNA helicase II by chemotherapeutic agents.
Topics: Adenosine Triphosphatases; Amsacrine; Antineoplastic Agents; Aphidicolin; Camptothecin; Dactinomycin; Daunorubicin; DNA; DNA Helicases; Ellipticines; Enzyme Inhibitors; Ethidium; Etoposide; Genistein; Humans; Isoflavones; Nogalamycin; Novobiocin; Topoisomerase I Inhibitors | 1997 |
Azatoxin is a mechanistic hybrid of the topoisomerase II-targeted anticancer drugs etoposide and ellipticine.
Topics: Amino Acid Substitution; Animals; Antineoplastic Agents; Cattle; DNA; Drosophila; Drug Design; Ellipticines; Enzyme Inhibitors; Etoposide; Humans; Indoles; Intercalating Agents; Kinetics; Molecular Structure; Recombinant Proteins; Saccharomyces cerevisiae; Thymus Gland; Topoisomerase II Inhibitors | 1997 |
Inhibition of pea chloroplast DNA helicase unwinding and ATPase activities by DNA-interacting ligands.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Amsacrine; Camptothecin; Chloroplasts; Dactinomycin; Daunorubicin; DNA Helicases; Ellipticines; Ethidium; Etoposide; Genistein; Hydrolysis; Intercalating Agents; Ligands; Nogalamycin; Novobiocin; Pisum sativum | 1998 |
Detection of topoisomerase inhibitor-induced DNA strand breaks and apoptosis by the alkaline comet assay.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Cell Survival; CHO Cells; Comet Assay; Cricetinae; DNA Damage; DNA Fragmentation; Ellipticines; Enzyme Inhibitors; Etoposide; Formazans; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Topotecan | 2002 |
Effect of a single nucleotide polymorphism in the murine double minute 2 promoter (SNP309) on the sensitivity to topoisomerase II-targeting drugs.
Topics: Amsacrine; Animals; Antineoplastic Agents; Cell Line, Tumor; DNA Topoisomerases, Type II; Drug Resistance, Neoplasm; Ellipticines; Etoposide; Humans; Immunoblotting; Mice; Microscopy, Confocal; Mitoxantrone; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Proto-Oncogene Proteins c-mdm2; Reverse Transcriptase Polymerase Chain Reaction | 2007 |
Inhibition of unwinding and ATPase activities of pea MCM6 DNA helicase by actinomycin and nogalamycin.
Topics: Adenosine Triphosphatases; Camptothecin; Cisplatin; Dactinomycin; Daunorubicin; DNA Helicases; Ellipticines; Enzyme Inhibitors; Etoposide; Intercalating Agents; Mitoxantrone; Nogalamycin; Novobiocin; Pisum sativum; Plant Proteins | 2011 |
The effects of anti-DNA topoisomerase II drugs, etoposide and ellipticine, are modified in root meristem cells of Allium cepa by MG132, an inhibitor of 26S proteasomes.
Topics: Allium; Cysteine Proteinase Inhibitors; Ellipticines; Etoposide; Histones; Leupeptins; Meristem; Phosphorylation; Plant Roots; Proteasome Endopeptidase Complex; Topoisomerase II Inhibitors | 2015 |
The impact of chemotherapeutic drugs on the CYP1A1-catalysed metabolism of the environmental carcinogen benzo[a]pyrene: Effects in human colorectal HCT116 TP53(+/+), TP53(+/-) and TP53(-/-) cells.
Topics: Activation, Metabolic; Benzo(a)pyrene; Carcinogens; Cell Survival; Cisplatin; Colorectal Neoplasms; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP3A; DNA Adducts; DNA Damage; Ellipticines; Enzyme Induction; Etoposide; Genes, p53; HCT116 Cells; Humans; Tumor Suppressor Protein p53 | 2018 |